145 related articles for article (PubMed ID: 20657168)
1. Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.
Delany AM
Cancer Biol Ther; 2010 Jul; 10(1):65-7. PubMed ID: 20657168
[No Abstract] [Full Text] [Related]
2. Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines.
Zhivkova-Galunska M; Adwan H; Eyol E; Kleeff J; Kolb A; Bergmann F; Berger MR
Cancer Biol Ther; 2010 Jul; 10(1):54-64. PubMed ID: 20495387
[TBL] [Abstract][Full Text] [Related]
3. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
Kaleağasıoğlu F; Berger MR
World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
[TBL] [Abstract][Full Text] [Related]
4. A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo.
Rahman M; Chan AP; Tang M; Tai IT
PLoS One; 2011; 6(11):e26390. PubMed ID: 22069448
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin acts as a molecular switch to determine SPARC function in pancreatic cancer.
Munasinghe A; Malik K; Mohamedi F; Moaraf S; Kocher H; Jones L; Hill NJ
Cancer Lett; 2020 May; 477():88-96. PubMed ID: 32113990
[TBL] [Abstract][Full Text] [Related]
6. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer.
Su X; Xu BH; Zhou DL; Ye ZL; He HC; Yang XH; Zhang X; Liu Q; Ma JJ; Shao Q; Yang AK; He CY
Genomics; 2020 Nov; 112(6):4959-4967. PubMed ID: 32919020
[TBL] [Abstract][Full Text] [Related]
8. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
9. Matricellular Proteins Play a Potential Role in Acute Primary Angle Closure.
Wang J; Fu M; Liu K; Wang N; Zhang Z; Zhou M; Xu X
Curr Eye Res; 2018 Jun; 43(6):771-777. PubMed ID: 29558210
[TBL] [Abstract][Full Text] [Related]
10. The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review).
Rossi MK; Gnanamony M; Gondi CS
Int J Oncol; 2016 May; 48(5):1765-71. PubMed ID: 26983777
[TBL] [Abstract][Full Text] [Related]
11. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
12. Stromal expression of SPARC in pancreatic adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Cros J; Faivre S; Hammel P; Raymond E
Cancer Metastasis Rev; 2013 Dec; 32(3-4):585-602. PubMed ID: 23690170
[TBL] [Abstract][Full Text] [Related]
13. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
Jiang X; Liu F; Wang Y; Gao J
J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
Arnold S; Mira E; Muneer S; Korpanty G; Beck AW; Holloway SE; Mañes S; Brekken RA
Exp Biol Med (Maywood); 2008 Jul; 233(7):860-73. PubMed ID: 18445772
[TBL] [Abstract][Full Text] [Related]
16. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
[TBL] [Abstract][Full Text] [Related]
17. Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats.
Komatsubara I; Murakami T; Kusachi S; Nakamura K; Hirohata S; Hayashi J; Takemoto S; Suezawa C; Ninomiya Y; Shiratori Y
Cardiovasc Pathol; 2003; 12(4):186-94. PubMed ID: 12826287
[TBL] [Abstract][Full Text] [Related]
18. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC.
Sodek J; Zhu B; Huynh MH; Brown TJ; Ringuette M
Connect Tissue Res; 2002; 43(2-3):308-19. PubMed ID: 12489175
[TBL] [Abstract][Full Text] [Related]
19. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
[TBL] [Abstract][Full Text] [Related]
20. EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN.
Zadvornyi T; Lukianova N; Borikun T; Gogol S; Virych P; Lykhova O; Chekhun V
Exp Oncol; 2022 Aug; 44(2):107-112. PubMed ID: 35964648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
